EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CRISPR screen identifies CEBPB as contributor to dyskeratosis congenita fibroblast senescence via augmented inflammatory gene response

Erik R Westin, Alireza Khodadadi-Jamayran, Linh K Pham, Moon Ley Tung, Frederick D Goldman

G3: Genes, Genomes, Genetics · 01.11.2023 · 13 (11)

DOI: 10.1093/g3journal/jkad207 ↗

Kurz gefasst

Fachartikel in der Zeitschrift G3: Genes, Genomes, Genetics, online erschienen am 17.09.2023. Verfasst von Erik R Westin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Hematology Oncology, University of Alabama at Birmingham, Birmingham, AL 35294, USA. Hauptthemen laut MEDLINE: Dyskeratosis Congenita, Telomerase. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAMS NIH HHS, NCI NIH HHS, Kaul Pediatric Research Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aging is the consequence of intra- and extracellular events that promote cellular senescence. Dyskeratosis congenita (DC) is an example of a premature aging disorder caused by underlying telomere/telomerase-related mutations. Cells from these patients offer an opportunity to study telomere-related aging and senescence. Our previous work has found that telomere shortening stimulates DNA damage responses (DDRs) and increases reactive oxygen species (ROS), thereby promoting entry into senescence. This work also found that telomere elongation via TERT expression, the catalytic component of the telomere-elongating enzyme telomerase, or p53 shRNA could decrease ROS by disrupting this telomere–DDR–ROS pathway. To further characterize this pathway, we performed a CRISPR/Cas9 knockout screen to identify genes that extend life span in DC cells. Of the cellular clones isolated due to increased life span, 34% had a guide RNA (gRNA) targeting CEBPB, while gRNAs targeting WSB1, MED28, and p73 were observed multiple times. CEBPB is a transcription factor associated with activation of proinflammatory response genes suggesting that inflammation may be present in DC cells. The inflammatory response was investigated using RNA sequencing to compare DC and control cells. Expression of inflammatory genes was found to be significantly elevated (P < 0.0001) in addition to a key subset of these inflammation-related genes [IL1B, IL6, IL8, IL12A, CXCL1 (GROa), CXCL2 (GROb), and CXCL5]. which are regulated by CEBPB. Exogenous TERT expression led to downregulation of RNA/protein CEBPB expression and the inflammatory response genes suggesting a telomere length-dependent mechanism to regulate CEBPB. Furthermore, unlike exogenous TERT and p53 shRNA, CEBPB shRNA did not significantly decrease ROS suggesting that CEBPB's contribution in DC cells’ senescence is ROS independent. Our findings demonstrate a key role for CEBPB in engaging senescence by mobilizing an inflammatory response within DC cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dyskeratosis CongenitaTelomeraseHumansReactive Oxygen SpeciesTumor Suppressor Protein p53MutationTelomereRNA, Small InterferingFibroblastsInflammationMediator ComplexCCAAT-Enhancer-Binding Protein-beta

Stichwörter der Autor:innen

CEBPBMED28WSB1p73CRISPRDyskeratosis congenitahuman primary fibroblastsinflammatory responseoxidative stresstelomere

Substanzen

Reactive Oxygen SpeciesTelomeraseTumor Suppressor Protein p53RNA, Small InterferingMED28 protein, humanMediator ComplexCEBPB protein, humanCCAAT-Enhancer-Binding Protein-beta

Autor:innen und Institutionen

  • Department of Pediatrics, Division of Hematology Oncology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
  • Department of Cancer Precision Medicine, Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, LA 70808, USA.
  • Genome Technology Center, Applied Bioinformatics Laboratories, NYU Langone Medical Center, New York, NY 10016, USA.
  • Stead Family Department of Pediatrics, Division of Medical Genetics and Genomics, University of Iowa, Iowa City, IA 52242, USA.

Förderung

  • NIAMS NIH HHS
  • NCI NIH HHS
  • Kaul Pediatric Research Institute
  • Department of Defense
  • The Comprehensive Flow Cytometry Core
  • Heflin Center for Genomic Sciences Core

Zitieren

APA

Westin, E. R., Khodadadi-Jamayran, A., Pham, L. K., Tung, M. L., & Goldman, F. D. (2023). CRISPR screen identifies CEBPB as contributor to dyskeratosis congenita fibroblast senescence via augmented inflammatory gene response. G3: Genes, Genomes, Genetics, 13(11). https://doi.org/10.1093/g3journal/jkad207

Vancouver

Westin ER, Khodadadi-Jamayran A, Pham LK, Tung ML, Goldman FD. CRISPR screen identifies CEBPB as contributor to dyskeratosis congenita fibroblast senescence via augmented inflammatory gene response. G3: Genes, Genomes, Genetics. 2023;13(11). doi:10.1093/g3journal/jkad207

BibTeX
@article{Westin2023,
  author = {Westin, Erik R and Khodadadi-Jamayran, Alireza and Pham, Linh K and Tung, Moon Ley and Goldman, Frederick D},
  title = {CRISPR screen identifies CEBPB as contributor to dyskeratosis congenita fibroblast senescence via augmented inflammatory gene response},
  journal = {G3: Genes, Genomes, Genetics},
  year = {2023},
  volume = {13},
  number = {11},
  doi = {10.1093/g3journal/jkad207}
}
Kostenlos starten →